Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FEMY Femasys	$0.57 +0.6%	$0.86	$0.55 ▼ $1.80	$18.49M	-2.58	329,193 shs	1.04 million shs
PETV PetVivo	$0.85 +2.1%	$0.79	$0.40 ▼ $0.98	$23.72M	0.66	19,305 shs	300 shs
RVP Retractable Technologies	$0.83 -0.9%	$0.71	$0.56 ▼ $0.99	$24.76M	1.15	59,025 shs	208,955 shs
STRR Star Equity	$2.72 +27.5%	$2.05	$1.72 ▼ $4.55	$6.89M	0.94	141,394 shs	1.82 million shs

Beginner's Guide To Retirement Stocks

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FEMY Femasys	-8.66%	-23.56%	-35.17%	-45.43%	-45.43%
PETV PetVivo	-0.30%	+6.15%	-0.42%	+4.06%	+66.50%
RVP Retractable Technologies	-1.64%	+7.72%	+24.60%	+28.63%	-13.04%
STRR Star Equity	+1.43%	-2.74%	+0.95%	+6.50%	-49.41%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
FEMY Femasys	3.2468 of 5 stars	3.5	3.0	0.0	0.0	3.2	2.5	0.6
PETV PetVivo	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
RVP Retractable Technologies	1.774 of 5 stars	0.0	3.0	0.0	0.0	3.2	3.3	0.6
STRR Star Equity	2.6768 of 5 stars	3.0	3.0	0.0	0.0	2.3	1.7	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
FEMY Femasys	3.00	Buy	$7.33	1,184.30% Upside
PETV PetVivo	0.00	N/A	N/A	N/A
RVP Retractable Technologies	0.00	N/A	N/A	N/A
STRR Star Equity	2.00	Hold	$5.00	84.09% Upside

Current Analyst Ratings Breakdown

Latest STRR, RVP, FEMY, and PETV Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/14/2025	STRR Star Equity	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold
8/11/2025	FEMY Femasys	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$12.00 ➝ $8.00
6/25/2025	FEMY Femasys	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$12.00
6/11/2025	FEMY Femasys	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$12.00

(Data available from 8/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
FEMY Femasys	$1.63M	11.41	N/A	N/A	$0.05 per share	11.42
PETV PetVivo	$1.05M	22.67	N/A	N/A	($0.03) per share	-28.33
RVP Retractable Technologies	$38.16M	0.65	$0.02 per share	48.25	$3.31 per share	0.25
STRR Star Equity	$53.36M	0.16	$0.42 per share	6.53	$11.31 per share	0.24

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
FEMY Femasys	-$18.82M	-$0.86	N/A	N/A	N/A	-1,113.72%	-713.74%	-152.60%	N/A
PETV PetVivo	-$10.95M	-$0.40	N/A	∞	N/A	-902.82%	-4,813.07%	-281.78%	N/A
RVP Retractable Technologies	-$7.01M	-$0.29	N/A	∞	N/A	-41.11%	-17.15%	-9.33%	N/A
STRR Star Equity	-$10.44M	-$1.02	N/A	N/A	N/A	-3.19%	12.87%	5.01%	N/A

Latest STRR, RVP, FEMY, and PETV Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/13/2025	Q2 2025	STRR Star Equity	-$0.26	$1.86	+$2.12	$1.07	$16.75 million	$23.71 million
8/8/2025	Q2 2025	FEMY Femasys	-$0.18	-$0.16	+$0.02	-$0.16	$0.80 million	$0.41 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
FEMY Femasys	N/A	N/A	N/A	N/A	N/A
PETV PetVivo	N/A	N/A	N/A	N/A	N/A
RVP Retractable Technologies	N/A	N/A	N/A	N/A	N/A
STRR Star Equity	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
FEMY Femasys	0.03	0.89	0.41
PETV PetVivo	0.02	0.42	0.47
RVP Retractable Technologies	0.01	8.57	5.92
STRR Star Equity	0.19	1.51	1.12

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
FEMY Femasys	65.27%
PETV PetVivo	24.55%
RVP Retractable Technologies	7.58%
STRR Star Equity	3.84%

Insider Ownership

Company	Insider Ownership
FEMY Femasys	11.54%
PETV PetVivo	10.84%
RVP Retractable Technologies	57.10%
STRR Star Equity	33.51%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
FEMY Femasys	30	32.58 million	28.82 million	Not Optionable
PETV PetVivo	20	27.90 million	19.06 million	Not Optionable
RVP Retractable Technologies	240	29.94 million	13.47 million	Optionable
STRR Star Equity	460	3.23 million	2.15 million	Not Optionable

STRR, RVP, FEMY, and PETV Headlines

Recent News About These Companies

Hudson Global, Star Equity announce closing of merger

3 hours ago | msn.com

Star Equity Holdings Approves Merger with Hudson Subsidiary

August 22 at 8:55 AM | msn.com

Hudson Global and Star Equity Holdings Announce Closing of Merger

August 22 at 8:30 AM | globenewswire.com

Star Equity's (STRR) Hold Rating Reiterated at Maxim Group

August 17, 2025 | americanbankingnews.com

Maxim Group Downgrades Star Equity Holdings (STRR)

August 15, 2025 | msn.com

Star Equity downgraded to Hold from Buy at Maxim

August 14, 2025 | msn.com

Star Equity Holdings Reports Strong Q2 2025 Results

August 14, 2025 | msn.com

Star Equity Holdings, Inc. (NASDAQ:STRR) Q2 2025 Earnings Call Transcript

August 14, 2025 | insidermonkey.com

Star Equity reports Q2 EPS $1.86 vs (29c) last year

August 13, 2025 | msn.com

Star Equity Holdings, Inc. (STRR) Q2 2025 Earnings Call Transcript

August 13, 2025 | seekingalpha.com

Star Equity (STRR) Tops Q2 Earnings and Revenue Estimates

August 13, 2025 | zacks.com

Star Equity Holdings, Inc. Announces 2025 Second Quarter Financial Results

August 13, 2025 | globenewswire.com

Earnings Outlook For Star Equity Hldgs

August 12, 2025 | benzinga.com

Star Equity Holdings Inc (STRR) Q2 2025 Earnings Report Preview: What To Expect

August 12, 2025 | finance.yahoo.com

Star Equity (STRR) Projected to Post Earnings on Wednesday

August 12, 2025 | americanbankingnews.com

Star Equity Holdings, Inc. Declares a Partial Cash Dividend of $0.225 Per Share of 10% Series A Cumulative Perpetual Preferred Stock

August 8, 2025 | globenewswire.com

STAR EQUITY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Star Equity Holdings, Inc. - STRR

August 5, 2025 | businesswire.com

Star Equity Holdings to Release Second Quarter 2025 Financial Results on August 13

August 4, 2025 | globenewswire.com

STAR EQUITY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Star Equity ...

May 24, 2025 | morningstar.comM

$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Star Equity Holdings, Inc. (NASDAQ: STRR)

May 24, 2025 | financialpost.comF

New MarketBeat Followers Over Time

Media Sentiment Over Time

STRR, RVP, FEMY, and PETV Company Descriptions

Femasys NASDAQ:FEMY

$0.57 +0.00 (+0.62%)

Closing price 04:00 PM Eastern

Extended Trading

$0.58 +0.01 (+1.23%)

As of 07:58 PM Eastern

Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

PetVivo NASDAQ:PETV

$0.85 +0.02 (+2.10%)

As of 03:57 PM Eastern

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

Retractable Technologies NYSE:RVP

$0.83 0.00 (-0.57%)

As of 04:00 PM Eastern

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

Star Equity NASDAQ:STRR

$2.72 +0.59 (+27.51%)

Closing price 08/21/2025 08:00 PM Eastern

Extended Trading

$2.72 0.00 (0.00%)

As of 08/21/2025 08:00 PM Eastern

Star Equity Holdings, Inc. engages in the construction business in the United States and internationally. It operates through two segments: Construction, and Investments. It manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time